ÖZASLAN, E. Et Al. 2015. Are Rogerofenib and Nilotinib Effective for Advanced Gastrointestinal Stromal Tumor (GIST) Patients who have Already been Given Main Treatments?. Asian Pacific Journal Of Cancer Prevention , vol.16, no.11 , 4801-4802.

ÖZASLAN, E., ÖZKAN, M., BOZKURT, O., OCAK DURAN, A., UÇAR, M., EKER, B., ... BERK, V.(2015). Are Rogerofenib and Nilotinib Effective for Advanced Gastrointestinal Stromal Tumor (GIST) Patients who have Already been Given Main Treatments?. Asian Pacific Journal Of Cancer Prevention , vol.16, no.11, 4801-4802.

ÖZASLAN, Ersin Et Al. "Are Rogerofenib and Nilotinib Effective for Advanced Gastrointestinal Stromal Tumor (GIST) Patients who have Already been Given Main Treatments?," Asian Pacific Journal Of Cancer Prevention , vol.16, no.11, 4801-4802, 2015

ÖZASLAN, Ersin Et Al. "Are Rogerofenib and Nilotinib Effective for Advanced Gastrointestinal Stromal Tumor (GIST) Patients who have Already been Given Main Treatments?." Asian Pacific Journal Of Cancer Prevention , vol.16, no.11, pp.4801-4802, 2015

ÖZASLAN, E. Et Al. (2015) . "Are Rogerofenib and Nilotinib Effective for Advanced Gastrointestinal Stromal Tumor (GIST) Patients who have Already been Given Main Treatments?." Asian Pacific Journal Of Cancer Prevention , vol.16, no.11, pp.4801-4802.

@article{article, author={Ersin ÖZASLAN Et Al. }, title={Are Rogerofenib and Nilotinib Effective for Advanced Gastrointestinal Stromal Tumor (GIST) Patients who have Already been Given Main Treatments?}, journal={Asian Pacific Journal Of Cancer Prevention}, year=2015, pages={4801-4802} }